Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient

Abstract

This case report demonstrates that dual-tropic viruses, capable of using both co-receptors in phenotypic assays, can be inhibited by maraviroc if they have a CCR5 co-receptor preference in vivo.